Technological advancements in the fields of chemistry, medicine and biology have allowed for the creation of prescription drugs, over-the-counter medications and medical devices that can alleviate pain, eliminate infection and save lives. These products have already enhanced and saved countless lives, but there are some situations where a drug or device may be defective, inadequately tested or simply dangerous. When this occurs, patients can experience serious injuries or may even lose their lives. Even if the drug or device was approved by the Food and Drug Administration (FDA) and is legally on the market, the injured patient may have the right to move forward with a lawsuit against the drug company or device manufacturer.<\/p>\n
Prescription and over-the-counter medications are approved by the FDA if they are properly tested and manufactured and offer benefits that outweigh their known risks. Medical devices may be approved on the basis that they are \u201csubstantially equivalent\u201d to devices already approved and on the market for the same use or, for new devices, that they are reasonably effective and safe. In spite of approval requirements, products sometimes still make it to the shelves and into the hands of healthcare professionals when they can cause serious harm. They may also be improperly marketed or mislabeled. Accordingly, there are certain circumstances where the drug company or manufacturer of the medical device may be held liable.<\/p>\n
An injured patient may have grounds for a lawsuit if a drug was improperly marketed or labeled, manufactured incorrectly or inadequately tested. The following are basic examples of when a manufacturer may be held liable for injuries caused by one of their drugs or devices:<\/p>\n
\u0130ster \u00fcr\u00fcn\u00fcn kendisi, ister etiketlenme veya pazarlanma \u015fekli olsun, \u00fcreticinin nas\u0131l sorumlu tutulaca\u011f\u0131n\u0131 belirlemek \u00f6nemlidir. Bir hastan\u0131n yaralanmas\u0131ndan \u00fcreticinin kesinlikle sorumlu tutulabilece\u011fi baz\u0131 durumlar vard\u0131r; bu, hastan\u0131n, \u00fcreticinin hatas\u0131n\u0131 veya yanl\u0131\u015fl\u0131\u011f\u0131n\u0131 kan\u0131tlamas\u0131 gerekmedi\u011fi, yaln\u0131zca cihaz\u0131n veya ilac\u0131n kusurlu oldu\u011funu ve hastan\u0131n onu kulland\u0131\u011f\u0131n\u0131 ve yaraland\u0131\u011f\u0131n\u0131 kan\u0131tlamas\u0131na gerek olmad\u0131\u011f\u0131 anlam\u0131na gelir. . Bu, ilac\u0131n veya cihaz\u0131n yap\u0131sal bir tasar\u0131m veya \u00fcretim hatas\u0131na sahip oldu\u011fu durumlarda ge\u00e7erli olabilir. Uyar\u0131 etiketi veya kullan\u0131m talimat\u0131 yetersiz veya yanl\u0131\u015f ise, bu da ila\u00e7 davas\u0131<\/a> kesin sorumlulu\u011fa dayanmaktad\u0131r.<\/p>\n Tehlikeli bir ila\u00e7 veya kusurlu bir t\u0131bbi cihaz\u0131n neden oldu\u011fu yaralanmalar, hastan\u0131n ya\u015fam\u0131 \u00fczerinde derin bir etkiye sahip olabilir. Mali tazminat\u0131n geri kazan\u0131lmas\u0131, hastan\u0131n kaybedileni yeniden in\u015fa etmeye ve kurtarmaya \u00e7al\u0131\u015fmas\u0131na yard\u0131mc\u0131 olabilir. T\u0131bbi bak\u0131m, gelecekteki t\u0131bbi harcamalar, kaybedilen \u00fccretler, potansiyel kazan\u00e7 kayb\u0131, duygusal travma, ac\u0131 ve \u0131st\u0131rap ve muhtemelen cezai zararlar i\u00e7in tazminata h\u00fckmedilebilir. Her dava farkl\u0131 oldu\u011fundan, b\u00f6lgenizde bu t\u00fcr davalara bakma konusunda uzman bir avukatla g\u00f6r\u00fc\u015fmenizi \u00f6neririz. Bug\u00fcn Napoli Shkolnik PLLC ile ileti\u015fime ge\u00e7in.<\/p>","protected":false},"excerpt":{"rendered":" Re\u00e7eteli Bir \u0130la\u00e7 veya T\u0131bbi Cihaz Taraf\u0131ndan Zarar G\u00f6r\u00fclmesi Halinde Haklar\u0131n\u0131z Kimya, t\u0131p ve biyoloji alanlar\u0131ndaki teknolojik geli\u015fmeler re\u00e7eteli, re\u00e7etesiz sat\u0131lan ila\u00e7lar\u0131n yarat\u0131lmas\u0131na olanak sa\u011flam\u0131\u015ft\u0131r...<\/p>","protected":false},"featured_media":0,"menu_order":16,"template":"","practiceareas_category":[743],"class_list":["post-5900","practiceareas","type-practiceareas","status-publish","hentry","practiceareas_category-pharmaceutical-litigation"],"acf":[],"_links":{"self":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/practiceareas\/5900","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/practiceareas"}],"about":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/types\/practiceareas"}],"version-history":[{"count":0,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/practiceareas\/5900\/revisions"}],"wp:attachment":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/media?parent=5900"}],"wp:term":[{"taxonomy":"practiceareas_category","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/practiceareas_category?post=5900"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}Tazminat Aramak<\/h3>\n